Stock USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials U.S. NeuroSurgical Holdings, Inc.

Equities

USNU

US90336K1016

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 09:32:37 2024-04-26 am EDT 		5-day change 1st Jan Change
0.71 USD -0.56% Intraday chart for U.S. NeuroSurgical Holdings, Inc. -5.33% +57.78%
Apr. 05 U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 10 U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1.636 1.558 2.104 1.792 0.8626 4.178
Enterprise Value (EV) 1 2.504 1.355 0.2689 -0.3198 -0.6514 3.797
P/E ratio -3.89 x 11 x 3.95 x -2.86 x -0.65 x -5.12 x
Yield - - - - - -
Capitalization / Revenue 0.48 x 0.51 x 0.66 x 1.69 x - -
EV / Revenue 0.73 x 0.44 x 0.08 x -0.3 x - -
EV / EBITDA 1.39 x 0.54 x - - - -
EV / FCF -2.98 x 0.58 x 0.28 x -0.36 x 0.72 x -21.8 x
FCF Yield -33.6% 171% 363% -279% 140% -4.59%
Price to Book 0.54 x 0.49 x 0.57 x 0.63 x 0.7 x 6.48 x
Nbr of stocks (in thousands) 7,792 7,792 7,792 7,792 7,842 9,285
Reference price 2 0.2100 0.2000 0.2700 0.2300 0.1100 0.4500
Announcement Date 4/11/19 4/13/20 4/7/21 4/15/22 4/13/23 4/5/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.424 3.07 3.173 1.061 - -
EBITDA 1 1.797 2.493 - - - -
EBIT 1 0.794 1.49 1.615 -0.089 -1.071 -0.765
Operating Margin 23.19% 48.53% 50.9% -8.39% - -
Earnings before Tax (EBT) 1 -0.613 0.151 0.856 -0.554 -1.533 -0.816
Net income 1 -0.421 0.142 0.533 -0.627 -1.337 -0.816
Net margin -12.3% 4.63% 16.8% -59.1% - -
EPS 2 -0.0540 0.0182 0.0684 -0.0805 -0.1705 -0.0879
Free Cash Flow 1 -0.8404 2.322 0.9768 0.8925 -0.9094 -0.1744
FCF margin -24.54% 75.65% 30.78% 84.12% - -
FCF Conversion (EBITDA) - 93.16% - - - -
FCF Conversion (Net income) - 1,635.48% 183.26% - - -
Dividend per Share - - - - - -
Announcement Date 4/11/19 4/13/20 4/7/21 4/15/22 4/13/23 4/5/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.87 - - - - -
Net Cash position 1 - 0.2 1.84 2.11 1.51 0.38
Leverage (Debt/EBITDA) 0.483 x - - - - -
Free Cash Flow 1 -0.84 2.32 0.98 0.89 -0.91 -0.17
ROE (net income / shareholders' equity) -13.1% 4.61% 15.6% -19.2% -70.1% -77.7%
ROA (Net income/ Total Assets) 7.03% 16.6% 22% -1.42% -24.6% -31.2%
Assets 1 -5.989 0.8541 2.421 44.3 5.428 2.618
Book Value Per Share 2 0.3900 0.4000 0.4700 0.3600 0.1600 0.0700
Cash Flow per Share 2 0.1900 0.1700 0.2600 0.2800 0.2000 0.0500
Capex 1 0.57 - - - - -
Capex / Sales 16.65% - - - - -
Announcement Date 4/11/19 4/13/20 4/7/21 4/15/22 4/13/23 4/5/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
U.S. NEUROSURGICAL HOLDINGS, INC. Stock U.S. NeuroSurgical Holdings, Inc.
+57.78% 9.45M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. USNU Stock
  4. Financials U.S. NeuroSurgical Holdings, Inc.